KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Operating Expenses (2017 - 2025)

Historic Operating Expenses for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $364.2 million.

  • Guardant Health's Operating Expenses rose 1793.4% to $364.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 1139.49%. This contributed to the annual value of $1.2 billion for FY2024, which is 477.88% up from last year.
  • According to the latest figures from Q3 2025, Guardant Health's Operating Expenses is $364.2 million, which was up 1793.4% from $338.5 million recorded in Q2 2025.
  • Guardant Health's Operating Expenses' 5-year high stood at $364.2 million during Q3 2025, with a 5-year trough of $186.5 million in Q1 2021.
  • Its 5-year average for Operating Expenses is $268.8 million, with a median of $262.8 million in 2023.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 8211.71% in 2021, then plummeted by 703.02% in 2024.
  • Over the past 5 years, Guardant Health's Operating Expenses (Quarter) stood at $206.3 million in 2021, then soared by 32.33% to $273.0 million in 2022, then grew by 29.14% to $352.6 million in 2023, then dropped by 7.03% to $327.8 million in 2024, then grew by 11.11% to $364.2 million in 2025.
  • Its last three reported values are $364.2 million in Q3 2025, $338.5 million for Q2 2025, and $314.5 million during Q1 2025.